A vs ADMA: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Adma Biologics Inc in 2026
A
Agilent Technologies Inc
$121.87
ADMA
Adma Biologics Inc
$11.01
Key Metrics Comparison
| Metric | A | ADMA | Winner |
|---|---|---|---|
| Market Cap | $34.47B | $2.62B | A |
| P/E Ratio | 26.90 | 18.35 | ADMA |
| EPS (TTM) | $4.53 | $0.60 | A |
| Revenue Growth | 0.1% | 0.2% | ADMA |
| Gross Margin | 52.3% | 57.4% | ADMA |
Analyze A
Full quant analysis
Analyze ADMA
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or ADMA a better investment?
Comparing A and ADMA: Agilent Technologies Inc has a market cap of $34.47B while Adma Biologics Inc has $2.62B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and ADMA?
A (Agilent Technologies Inc) and ADMA (Adma Biologics Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or ADMA?
Based on P/E ratios, ADMA trades at a lower multiple (18.4x vs 26.9x).
Which is growing faster: A or ADMA?
ADMA has higher revenue growth at 0.2% vs 0.1% for A.
Which company is more profitable: A or ADMA?
Adma Biologics Inc (ADMA) has higher gross margins at 57.4% compared to 52.3% for A.
Which is the larger company: A or ADMA?
Agilent Technologies Inc (A) is larger with a market cap of $34.47B compared to $2.62B for ADMA.
Should I buy A or ADMA in 2026?
Both A and ADMA have investment merit. A trades at $121.87 while ADMA trades at $11.01. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and ADMA stock?
Key differences: Market Cap ($34.47B vs $2.62B), P/E Ratio (26.9x vs 18.4x), Revenue Growth (0.1% vs 0.2%), Gross Margin (52.3% vs 57.4%).